Kafui Dzirasa, MD, PhD will deliver a presentation titled "Next Generation Neuropsychiatric Diagnostics and Therapeutics” at the Duke Psychiatry and Behavioral Sciences Grand Rounds. The event will be held on Thursday, May 26 from noon to 1 p.m. in Duke North Lecture Hall 2002.
By the end of the session, participants should be able to:
1. Accurately describe three distinct barriers to dissecting the neural circuit mechanisms underlying emotional behaviors.
2. Accurately identify three differences between action potentials and local field potentials.
3. Accurately describe three differences between optogenetic and electrical stimulation.
Dr. Dzirasa received his BS in Chemical Engineering from University of Maryland Baltimore County before earning his PhD in Neurobiology at Duke University and his MD at Duke University School of Medicine. He will complete his residency training in the Duke Psychiatry Residency Training Program in June. His research interests focus on understanding how changes in the brain produce neurological and mental illness, and his graduate work led to several distinctions including: the Somjen Award for Most Outstanding Dissertation Thesis, the Ruth K. Broad Biomedical Research Fellowship, the UNCF-Merck Graduate Science Research Fellowship, and the Wakeman Fellowship. Dr. Dzirasa has served on the Board of Directors of the Student National Medical Association, a national organization dedicated to the eradication of health care disparities. He received the Charles Johnson Leadership Award in 2007, and he was recognized as one of Ebony magazine’s 30 Young Leaders of the Future in February 2008. He has also been awarded the International Mental Health Research Organization Rising Star Award and the Sydney Baer Prize for Schizophrenia Research. His laboratory was featured on CBS 60 Minutes in 2011, and in 2016 he was awarded the Presidential Early Career Award for Scientists and Engineers. Dr. Dzirasa’s ultimate goal is to combine his research background, medical training, and community experience to improve outcomes for communities suffering from neurological and psychiatric illness.